Sc610 cell therapy（ Sun Yat-Sen University）

N/A

Report date: 2022/12/02 20:01:16

Base Information

Drug NameSc610 cell therapy（ Sun Yat-Sen University）
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vectorCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyCell and gene therapy > Cell therapy > Source of cells > PMBC-derived
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsUrologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSun Yat-Sen Memorial Hospital Of Sun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesSun Yat-Sen Memorial Hospital Of Sun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsUrologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A